It’s only fair to share… BBIBP-CorV, Sinopharm COVID-19 vaccine CAS Number 2503126-65-4 Inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) Purified inactivated SARS-CoV-2 Vaccine ref Lancet Infectious Diseases (2021), 21(1), 39-51. BBIBP-CorV, also known as the Sinopharm COVID-19 vaccine,[1] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. In late December 2020, it was in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 …